Table 1.
GMM Network Modules with Enriched Clinical Annotations.
| Cancer Types | ||||||
| BLCA | OV | LGG | THCA | GBM | ||
| 13 | 15 | 32 | 9 | 18 | ||
| Gender | ||||||
| Female | Male | |||||
| 11 | 22 | |||||
| Cancer Stage | ||||||
| Stage I | Stage II | Stage III | Stage IV | Stage IVA | Stage IVC | |
| 10 | 3 | 0 | 10 | 5 | 0 | |
| Ethnicity * | ||||||
| NHL | HL | W | AA | A | NHPI | AIAN |
| 2 | 3 | 22 | 0 | 6 | 0 | 0 |
Each value indicates the number of modules in the GMM network enriched for the specified annotation with a p-value < 0.001. BLCA (bladder cancer), OV (ovarian cancer), LGG (lower grade glioma), THCA (thyroid cancer), GBM (glioblastoma), NHL (not Hispanic or Latino), HL (Hispanic or Latino), W (White), AA (African American), A (Asian), NHPI (Native Hawaiian or Pacific Islander), AIAN (American Indian, Alaska Native).